Literature DB >> 28106938

Vascular endothelial growth factor-targeted paclitaxel-loaded liposome microbubbles and inhibition of human epidermoid-2 cell proliferation.

Lian Zhou1, Wenlong Luo1.   

Abstract

BACKGROUND: Vascular endothelial growth factor (VEGF) plays an important role in the formation of capillary blood vessels. The purpose of this study was to evaluate the inhibitory effect of VEGF-targeted paclitaxel (PTX)-loaded liposome microbubbles (VTPLLMs) on the proliferation of human epidermoid (Hep-2) laryngeal squamous cell carcinoma (SCC).
METHODS: Six groups were randomly divided. The inhibitory effects on Hep-2 proliferation were assessed by a methylthiazol tetrazolium (MTT) method. The cell cycle distributions were investigated by flow cytometry. The expression variations of VEGF and caspase-3 were compared by Western blotting.
RESULTS: Proliferation of Hep-2 in the VTPLLM+ultrasound group was significantly inhibited, and flow cytometry showed that the Hep-2 cells were significantly blocked at stage G2/M compared with other groups. Moreover, Western blotting showed VEGF expression was downregulated and caspase-3 expression was upregulated.
CONCLUSION: VTPLLMs can efficiently inhibit tumor cell proliferation and outperform nontargeted microbubbles or PTX.
© 2017 Wiley Periodicals, Inc. Head Neck 39: 656-661, 2017. © 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  human epidermoid carcinoma cells (Hep-2); inhibition effect; targeted therapy; ultrasound microbubbles; vascular endothelial growth factor (VEGF)

Mesh:

Substances:

Year:  2017        PMID: 28106938     DOI: 10.1002/hed.24648

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  1 in total

1.  A Gastric Cancer Peptide GX1-Modified Nano-Lipid Carriers Encapsulating Paclitaxel: Design and Evaluation of Anti-Tumor Activity.

Authors:  Yufan Jian; Meina Zhao; Jinyi Cao; Tingting Fan; Wei Bu; Yang Yang; Weiwei Li; Wei Zhang; Yi Qiao; Jingwen Wang; Aidong Wen
Journal:  Drug Des Devel Ther       Date:  2020-06-12       Impact factor: 4.162

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.